" "
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Scientists Discover New Biological Marker for Parkinson's Disease

Published: Friday, September 20, 2013
Last Updated: Friday, September 20, 2013
Bookmark and Share
Researchers discover new biological indicator to track Parkinson’s disease using powerful MRI scanners.

Researchers in Nottingham have discovered a new biological indicator which could potentially help to track the progress of Parkinson’s disease using powerful MRI scanners.

Using highly sensitive new brain imaging techniques, scientists from The University of Nottingham and clinicians at Nottingham University Hospitals NHS Trust have discovered a measurable trait on the human brain which could be used not only to diagnose the condition but potentially also to track progression of the disease.

Parkinson’s develops when dopamine producing nerve cells in the brain die. Current diagnostic imaging tests using nuclear medical techniques are costly and cannot be used to monitor disease progression.

There has been a need for such imaging tracking in Parkinson’s disease to allow for the development of neuroprotective drugs through clinical trials.

In a paper published in the journal Neurology, the Nottingham researchers led by Penny, Gowland, Professor of Physics, reveal that this new discovery could potentially lead to a new diagnostic test for the disease.

Professor Gowland, who is based at the University’s Sir Peter Mansfield Magnetic Resonance Centre, said: “When conducting a different study of patients with Parkinson’s, by using a 7T MRI scanner (which is an extremely powerful MRI scanner), we discovered a mark which looked like a ‘tear drop’ on the brains of healthy subjects, and this was not visible in the brains of patients. In subsequent post mortem scans, we actually discovered that this was something called nigrosome 1. It was known from previous post mortem work that nigrosome 1 could not be found in brains of Parkinson’s disease patients.

‘So this was a breakthrough discovery in that we now know that using this particularly sensitive MRI scanner, we can see that patients living with Parkinson’s disease don’t have this particular feature in their brain.”

Now, researchers will take their findings and look into how this discovery can be translated into standard MRI scans used in most hospitals.

Professor Gowland added: “We are now conducting a study of patients with Parkinson’s to ascertain when this mark actually disappears, which could potentially have huge implications for early diagnosis of the illness, and subsequently how it is treated.”

Dr Nin Bajaj, Associate Honorary Clinical Professor in Neurology at Nottingham University Hospitals NHS Trust, said: “By using highly accurate and sensitive brain imaging techniques for Parkinson’s we are able to get an insight into the mechanism that causes the disease for the first time.

“We have been trying to find a biological marker for Parkinson’s for many years and the reason is that we need a tool to measure change in the disease in clinical trials in a very sensitive way. This discovery is a step change in Parkinson’s disease, it’s a game changer as they say and the implications are potentially huge.”

A full copy of the research paper can be viewed on the Neurology website. The research involved academics at The University of Nottingham’s Sir Peter Mansfield Magnetic Resonance Centre, Division of Radiological and Imaging Sciences and School of Psychology in collaboration with the Divisions of Pathology and Neurology at Nottingham University Hospitals NHS Trust.

The work was funded by the Medical Research Council and the Engineering and Physical Sciences Research Council (EPSRC).

The Sir Peter Mansfield Magnetic Resonance Centre is named after The University of Nottingham professor who played a central role in the development of MRI technology which revolutionized diagnostic medicine in hospitals around the world.

His contribution to the discovery earned him the Nobel Prize for Medicine in 2003.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
'Molecular Movie' Opens Door to New Cancer Treatments
An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Preparing for Potential Zika Outbreaks
Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!